Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urine-Based Diagnostics Tool Detects Tuberculosis

By LabMedica International staff writers
Posted on 25 May 2011
An optical biosensor diagnostics device detects tuberculosis in urine samples in 15-20 min.

The waveguide-based system is capable of providing a qualitative tuberculosis diagnosis in a very short time using only a few drops of human urine. More...
This is a significant breakthrough compared to sputum, blood, and skin tests that often take several days or weeks for results. Recently developed polymerase chain reaction (PCR)-based diagnostics, which take approximately two hours to produce results, are significantly more expensive.

Biomagnetics Diagnostics Corporation (Orangevale, CA, USA) is currently developing the waveguide-based advanced integrated optical biosensor through its cooperative research and development agreement with Los Alamos National Security, LLC (Santa Fe, NM, USA). The biosensor will initially be used for cholera, tuberculosis, and malaria diagnosis.

The optical biosensor was introduced in a video that can be viewed online (please see Related Links below).

Clayton Hardman, CEO of Biomagnetics Diagnostics commented, "While the current cost profile is already significantly lower than other tests, we are already working on a new waveguide design that will likely allow us to reduce the cost per test even further. The unit shown in this video is a desktop unit; however, the products for ultimate delivery to the market will also include a handheld device that can be operated by relatively untrained medical personnel at the point of patient care. We see nothing on the market today, or on the immediate horizon, that can compare to the capabilities of this technology."

Related Links:
Biomagnetics Diagnostics Corporation
Los Alamos National Security, LLC
Optical Biosensor Video



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.